PLx Pharma Inc.·4

Aug 11, 9:02 AM ET

O'Connor Rita M 4

4 · PLx Pharma Inc. · Filed Aug 11, 2021

Insider Transaction Report

Form 4
Period: 2021-08-09
O'Connor Rita M
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-09+100,000100,000 total
    Exercise: $16.97Exp: 2031-08-09Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
  • [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.

Documents

1 file
  • 4
    form411577002oco_08112021.xmlPrimary

    OWNERSHIP DOCUMENT